CNO FINANCIAL GROUP INC (CNO) Stock Fundamental Analysis
USA - NYSE:CNO - US12621E1038 - Common Stock
39.61 USD
+0.11 (+0.28%)
39.61 USD
0 (0%)
Taking everything into account, CNO scores 4 out of 10 in our fundamental rating. CNO was compared to 147 industry peers in the Insurance industry. There are concerns on the financial health of CNO while its profitability can be described as average. CNO is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CNO was profitable.
CNO had a positive operating cash flow in the past year.
Each year in the past 5 years CNO has been profitable.
Each year in the past 5 years CNO had a positive operating cash flow.
1.2 Ratios
CNO has a Return On Assets of 0.75%. This is in the lower half of the industry: CNO underperforms 63.95% of its industry peers.
Looking at the Return On Equity, with a value of 11.13%, CNO is in line with its industry, outperforming 57.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.75% | ||
| ROE | 11.13% | ||
| ROIC | N/A |
ROA(3y)1.25%
ROA(5y)1.24%
ROE(3y)21.43%
ROE(5y)16.13%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CNO has a Profit Margin (6.32%) which is comparable to the rest of the industry.
CNO's Profit Margin has declined in the last couple of years.
CNO's Operating Margin of 14.15% is fine compared to the rest of the industry. CNO outperforms 66.67% of its industry peers.
CNO's Operating Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.15% | ||
| PM (TTM) | 6.32% | ||
| GM | N/A |
OM growth 3Y-3.08%
OM growth 5Y9.46%
PM growth 3Y-13.73%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The number of shares outstanding for CNO has been reduced compared to 1 year ago.
The number of shares outstanding for CNO has been reduced compared to 5 years ago.
Compared to 1 year ago, CNO has a worse debt to assets ratio.
2.2 Solvency
CNO has a debt to FCF ratio of 5.86. This is a neutral value as CNO would need 5.86 years to pay back of all of its debts.
CNO has a Debt to FCF ratio of 5.86. This is comparable to the rest of the industry: CNO outperforms 40.14% of its industry peers.
A Debt/Equity ratio of 1.64 is on the high side and indicates that CNO has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.64, CNO is doing worse than 91.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.64 | ||
| Debt/FCF | 5.86 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
CNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.40%, which is quite good.
CNO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.49% yearly.
Looking at the last year, CNO shows a small growth in Revenue. The Revenue has grown by 0.84% in the last year.
CNO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.35% yearly.
EPS 1Y (TTM)12.4%
EPS 3Y12.53%
EPS 5Y16.49%
EPS Q2Q%-17.14%
Revenue 1Y (TTM)0.84%
Revenue growth 3Y3.34%
Revenue growth 5Y2.35%
Sales Q2Q%5.4%
3.2 Future
Based on estimates for the next years, CNO will show a small growth in Earnings Per Share. The EPS will grow by 7.37% on average per year.
Based on estimates for the next years, CNO will show a small growth in Revenue. The Revenue will grow by 3.73% on average per year.
EPS Next Y-4.42%
EPS Next 2Y4.21%
EPS Next 3Y5.98%
EPS Next 5Y7.37%
Revenue Next Year3.38%
Revenue Next 2Y3.33%
Revenue Next 3Y3.31%
Revenue Next 5Y3.73%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 9.71, the valuation of CNO can be described as very reasonable.
Based on the Price/Earnings ratio, CNO is valued a bit cheaper than 65.31% of the companies in the same industry.
When comparing the Price/Earnings ratio of CNO to the average of the S&P500 Index (27.77), we can say CNO is valued rather cheaply.
CNO is valuated reasonably with a Price/Forward Earnings ratio of 9.14.
Based on the Price/Forward Earnings ratio, CNO is valued a bit cheaper than 62.59% of the companies in the same industry.
CNO is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.71 | ||
| Fwd PE | 9.14 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNO indicates a somewhat cheap valuation: CNO is cheaper than 70.75% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.45 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.59
EPS Next 2Y4.21%
EPS Next 3Y5.98%
5. Dividend
5.1 Amount
CNO has a Yearly Dividend Yield of 1.77%. Purely for dividend investing, there may be better candidates out there.
CNO's Dividend Yield is comparable with the industry average which is at 3.31.
CNO's Dividend Yield is slightly below the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.77% |
5.2 History
The dividend of CNO is nicely growing with an annual growth rate of 8.19%!
CNO has been paying a dividend for at least 10 years, so it has a reliable track record.
CNO has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)8.19%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
CNO pays out 23.78% of its income as dividend. This is a sustainable payout ratio.
CNO's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP23.78%
EPS Next 2Y4.21%
EPS Next 3Y5.98%
39.61
+0.11 (+0.28%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners97.53%
Inst Owner Change-0.1%
Ins Owners2.24%
Ins Owner Change-0.65%
Market Cap3.84B
Analysts50.77
Price Target43.25 (9.19%)
Short Float %1.79%
Short Ratio2.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.77% |
Yearly Dividend0.64
Dividend Growth(5Y)8.19%
DP23.78%
Div Incr Years12
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.34%
Min EPS beat(2)-0.86%
Max EPS beat(2)1.54%
EPS beat(4)3
Avg EPS beat(4)14.05%
Min EPS beat(4)-0.86%
Max EPS beat(4)33.4%
EPS beat(8)6
Avg EPS beat(8)17.33%
EPS beat(12)7
Avg EPS beat(12)8.38%
EPS beat(16)10
Avg EPS beat(16)13.2%
Revenue beat(2)2
Avg Revenue beat(2)9.2%
Min Revenue beat(2)1.91%
Max Revenue beat(2)16.5%
Revenue beat(4)4
Avg Revenue beat(4)12.5%
Min Revenue beat(4)1.91%
Max Revenue beat(4)19.67%
Revenue beat(8)8
Avg Revenue beat(8)14.37%
Revenue beat(12)12
Avg Revenue beat(12)11.81%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.47%
EPS NQ rev (1m)-0.14%
EPS NQ rev (3m)-2.01%
EPS NY rev (1m)0.2%
EPS NY rev (3m)0.13%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.71 | ||
| Fwd PE | 9.14 | ||
| P/S | 0.86 | ||
| P/FCF | 5.45 | ||
| P/OCF | 5.45 | ||
| P/B | 1.52 | ||
| P/tB | 1.52 | ||
| EV/EBITDA | N/A |
EPS(TTM)4.08
EY10.3%
EPS(NY)4.33
Fwd EY10.94%
FCF(TTM)7.27
FCFY18.35%
OCF(TTM)7.27
OCFY18.35%
SpS45.88
BVpS26.03
TBVpS26.03
PEG (NY)N/A
PEG (5Y)0.59
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.75% | ||
| ROE | 11.13% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 14.15% | ||
| PM (TTM) | 6.32% | ||
| GM | N/A | ||
| FCFM | 15.84% |
ROA(3y)1.25%
ROA(5y)1.24%
ROE(3y)21.43%
ROE(5y)16.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.15%
ROCE(5y)1.99%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.08%
OM growth 5Y9.46%
PM growth 3Y-13.73%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.64 | ||
| Debt/FCF | 5.86 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 250.77% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)148.25%
Profit Quality(5y)158.67%
High Growth Momentum
Growth
EPS 1Y (TTM)12.4%
EPS 3Y12.53%
EPS 5Y16.49%
EPS Q2Q%-17.14%
EPS Next Y-4.42%
EPS Next 2Y4.21%
EPS Next 3Y5.98%
EPS Next 5Y7.37%
Revenue 1Y (TTM)0.84%
Revenue growth 3Y3.34%
Revenue growth 5Y2.35%
Sales Q2Q%5.4%
Revenue Next Year3.38%
Revenue Next 2Y3.33%
Revenue Next 3Y3.31%
Revenue Next 5Y3.73%
EBIT growth 1Y-25.65%
EBIT growth 3Y0.16%
EBIT growth 5Y12.04%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.65%
FCF growth 3Y1.61%
FCF growth 5Y-2.06%
OCF growth 1Y27.65%
OCF growth 3Y1.61%
OCF growth 5Y-2.06%